Sex: F
Vaccine: RAB
Symptoms: Inappropriate schedule of product administration, Incomplete course of vaccination, No adverse event
Clinical narrative: The patient missed scheduled second dose of RabAvert for post-exposure and had it seven days after exposure, and did not receive any additional dose since; The patient missed scheduled second dose of RabAvert for post-exposure and had it seven days after exposure, and did not receive any additional dose since; Case reference number US-BN-2023-001028 is a spontaneous case report initially received from a physician via Agency (reference number: USBAV23-0767) on 16-Jun-2023 and concerns a *46-year-old* female patient.  The patient's medical history and concomitant medication details were not provided.  On 08-Jun-2023, *the patient was attacked by a dog and had multiple dog bites on the right forearm which caused pain (eight on a scale to ten, located the site of the injury, worse with any palpation or movement, no alleviating factors) and swelling.* On the same day, the patient was vaccinated with the first dose of RabAvert vaccine (batch number not provided), at an unknown dosage, *intramuscularly in the left arm* for post-exposure to rabies.  On 15-Jun-2023, seven days after the exposure, the patient was vaccinated with the second dose of RabAvert vaccine, at an unknown dosage, *intramuscularly in the left arm* (explicitly coded as 'inappropriate schedule of product administration'). As reported, the patient missed the second dose and only had it on 15-Jun-2023.  At the time of the follow-up report, the patient did not receive any additional doses of RabAvert (explicitly coded as an 'incomplete course of vaccination).  *As reported, there were no deviations or issues during the administration of the RabAvert.*  *The patient did not develop rabies disease or experienced any adverse events due to the RabAvert vaccine. *  Additional information received from Agency on 16-Jun-2023 included the local Agency case ID.  Additional information received from the physician on 19-Jun-2023 included date of the first vaccination with RabAvert and the date of exposure.  All follow-up information is blended into the case narrative above, with the latest information presented between asterisks (*).  Follow-up information was received from the physician on 01-Aug-2023: details of the animal exposure; route, and anatomical site for the first two doses of Rabavert. There was no information about additional doses which caused the non-event of 'incomplete course of vaccination to be added.; Reporter's Comments: A 46-year-old female patient was exposed to rabies through multiple dog bites on the right forearm, which caused pain and swelling. On the same day, the patient was vaccinated with the first dose of RabAvert vaccine, at unknown dose, intramuscularly in the left arm, as post-exposure rabies prophylaxis. Reportedly, on the day 7 after the exposure, the patient was vaccinated with the second dose of RabAvert vaccine, at unknown dose, intramuscularly in the left arm, which is considered as inappropriate schedule of product administration. The patient did not receive additional doses, which is considered incomplete course of vaccination. No deviations or issues occurred during the RabAvert vaccination. No associated adverse events were reported. Inappropriate schedule of product administration and incomplete course of vaccination are considered listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Inappropriate schedule of product administration and incomplete course of vaccination are considered not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 46-year-old female patient was exposed to rabies through multiple dog bites on the right forearm, which caused pain and swelling. On the same day, the patient was vaccinated with the first dose of RabAvert vaccine, at unknown dose, intramuscularly in the left arm, as post-exposure rabies prophylaxis. Reportedly, on the day 7 after the exposure, the patient was vaccinated with the second dose of RabAvert vaccine, at unknown dose, intramuscularly in the left arm, which is considered as inappropriate schedule of product administration. The patient did not receive additional doses, which is considered incomplete course of vaccination. No deviations or issues occurred during the RabAvert vaccination. No associated adverse events were reported. Inappropriate schedule of product administration and incomplete course of vaccination are considered listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Inappropriate schedule of product administration and incomplete course of vaccination are considered not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.